Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma.
Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma. Clin Cancer Res. 2017 Aug 15; 23(16):4633-4641.
View in:
PubMed
subject areas
Adolescent
Adolescent
Adult
Adult
Aged
Aged
Animals
Animals
Antibodies, Monoclonal
Antibodies, Monoclonal
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Hepatocellular
Carcinoma, Hepatocellular
Cell Line, Tumor
Cell Line, Tumor
Disease-Free Survival
Disease-Free Survival
Epistaxis
Epistaxis
Female
Female
Headache
Headache
Humans
Humans
Liver Neoplasms
Liver Neoplasms
Liver Neoplasms, Experimental
Liver Neoplasms, Experimental
Mice, Inbred BALB C
Mice, Inbred BALB C
Middle Aged
Middle Aged
Niacinamide
Niacinamide
Phenylurea Compounds
Phenylurea Compounds
Treatment Outcome
Treatment Outcome
Young Adult
Young Adult
authors with profiles
Susanna Ulahannan